← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Cytarabin currently has availability issues reported in 4 European registers: Germany, Spain, Italy, Sweden.
Shortage ATC L01BC01 · also listed as: Cytarabin · CITARABINA · data refreshed 12 September 2026
As of 12 September 2026, 4 of the 9 tracked registers list current availability issues for Cytarabin, covering 10 affected product presentations. The longest-running open report was filed in Sweden on 2024-09-27 and has now been open for about 24 months. Where agencies state a cause, manufacturing problems lead with 4 of the 5 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2027-12-31; the earliest is 2026-09-29. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Sweden reported first (2024-09-27), with Italy following roughly 24 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Cytarabin is coded L01BC01 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage ARA-cell 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung + 3 more productsARA-cell 1000mg Infusionslösung ARA-cell 4000mg Infusionslösung ARA-cell 40mg Injektion | 2025-10-07 | 2027-12-31 | Probleme in der Herstellung Alternatives: N/A | register ↗ |
| 🇪🇸 Spain | Shortage CITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 1 ml + 2 more productsCITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 5 ml CITARABINA PFIZER 20 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 25 ml | 2025-06-01 | 2026-11-29 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇹 Italy | Shortage CITARABINA ACCORD | 2026-10-01 | — | Motivi commerciali Alternatives: AIFA: an alternative treatment is available (ask your doctor). | register ↗ |
| 🇸🇪 Sweden | Shortage Cytarabine Accord 100 mg/ml Injektions-/infusionsvätska, lösning + 1 more productsCytarabine STADA 100 mg/ml Koncentrat till infusionsvätska, lösning | 2024-09-27 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Cytarabin in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | CITARABINA ACCORD | Shortage | 2026-10-01 | — | Motivi commerciali |
| 🇩🇪 DE | ARA-cell 40mg Injektion | Shortage | 2026-09-02 | 2027-12-31 | Probleme in der Herstellung |
| 🇸🇪 SE | Cytarabine Accord 100 mg/ml Injektions-/infusionsvätska, lösning | Shortage | 2026-07-01 | 2026-07-31 | |
| 🇪🇸 ES | CITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 v | Shortage | 2026-05-25 | 2026-11-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇩🇪 DE | ARA-cell 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung | Shortage | 2026-05-04 | 2027-12-31 | Probleme in der Herstellung |
| 🇩🇪 DE | ARA-cell 4000mg Infusionslösung | Shortage | 2026-03-14 | 2027-12-31 | Probleme in der Herstellung |
| 🇩🇪 DE | ARA-cell 1000mg Infusionslösung | Shortage | 2025-10-07 | 2027-12-31 | Probleme in der Herstellung |
| 🇪🇸 ES | CITARABINA PFIZER 20 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION, 1 via | Shortage | 2025-08-06 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | CITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 v | Shortage | 2025-06-01 | 2026-09-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇸🇪 SE | Cytarabine STADA 100 mg/ml Koncentrat till infusionsvätska, lösning | Shortage | 2024-09-27 | 2026-12-31 |
Yes. As of 12 September 2026, availability issues are reported in: Germany, Spain, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-29 to 2027-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
10 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Cytarabin: BfArM (Germany), AEMPS CIMA (Spain), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Cytarabin — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cytarabin/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Cytarabin availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cytarabin/">Cytarabin shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>